Scope
This is a focused summary of WGO's July 2016 coeliac disease guideline, including its resource-sensitive approach to testing, dietary treatment and follow-up. It emphasises that coeliac disease can present beyond childhood and without diarrhoea, and that symptomatic improvement on gluten withdrawal is not sufficient proof of the diagnosis. The recommendations below retain the source's date and should be read alongside current regional diagnostic guidance, especially for biopsy-sparing pathways.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Recognise varied presentations and higher-risk groups
- Consider coeliac testing with chronic/intermittent diarrhoea, iron-deficiency anaemia, weight loss or growth failure, delayed puberty, persistent fatigue, dermatitis-herpetiformis-like rash, low-trauma fracture or unexplained raised transaminases. Absence of malabsorption or gastrointestinal symptoms does not exclude the disease. [1]
- Use proactive case-finding in higher-risk groups rather than assuming that population-wide screening has a proven benefit. The source lists type 1 diabetes, autoimmune thyroid/liver disease, Down/Turner/Williams syndromes and selective IgA deficiency among associated conditions warranting serological testing. [1]
- Offer coeliac screening to first-degree relatives. Explain that disease risk is increased but a family relationship alone does not establish the diagnosis. [1]
Test before restricting gluten
- Do not diagnose coeliac disease solely from clinical impressions or improvement on a gluten-free diet when diagnostic testing is available. Improvement can reflect non-coeliac disease or other dietary changes, and premature gluten avoidance complicates assessment. [1]
- Use IgA tissue-transglutaminase antibodies together with total IgA as the usual first-line serological approach. In selective IgA deficiency, use an IgG-based test such as deamidated gliadin peptide, tTG or endomysial antibodies rather than treating a negative IgA test as reassuring. [1]
- The source advises repeat testing after 3–6 months on a gluten-containing diet for asymptomatic borderline serology, while symptomatic patients with borderline results should undergo biopsy assessment. Low positive titres can be false positives, including in thyroid or liver disease. [1]
- Do not use native antigliadin antibody tests to diagnose coeliac disease, or stool, urine or salivary coeliac-antibody tests in clinical practice; their performance is inadequate compared with the recommended blood tests. [1]
- HLA-DQ2/DQ8 testing is mainly useful to exclude coeliac disease in an uncertain diagnosis or before a formal gluten challenge. A positive risk genotype does not confirm the disease, because genetic susceptibility alone is insufficient. [1]
Interpret biopsy with serology and context
- When coeliac disease is clinically suspected, take duodenal biopsies even if folds look normal at endoscopy. Visible scalloping or other suggestive changes also warrant biopsy; the endoscopic appearance alone is insufficiently sensitive or specific. [1]
- Because lesions can be patchy, the source calls for four to six samples from the second duodenum and bulb while the patient is consuming gluten. Bulb sampling matters because disease may be confined there; a prior gluten-free diet needs an individual diagnostic plan rather than assuming a normal biopsy excludes disease. [1]
- Villous injury is characteristic but not specific. Consider other causes such as tropical sprue, giardiasis, immune deficiency, medication-related enteropathy and food-allergy enteropathy, particularly where these conditions are locally relevant. [1]
- Ask for a structured histology report including biopsy quality, intraepithelial lymphocytes and the modified Marsh interpretation. If fragments are poor-quality or unoriented, the source advises repeat multiple biopsies before gluten restriction rather than accepting an unreliable diagnosis. [1]
Build a sustainable, strict gluten-free diet
- For confirmed coeliac disease, follow a strict lifelong gluten-free diet excluding wheat, rye and barley and their derivatives, including gluten in foods and medicines. Do not interpret early symptom improvement as a cure that permits unrestricted gluten. [1]
- Use a dietitian experienced in coeliac disease, particularly during the first year, and provide education and access to an experienced patient-support group. Assess nutritional status and adherence through a dietary interview and food diary rather than only asking whether gluten is avoided. [1]
- Rice and maize can form part of the gluten-free diet. Gluten-free grains and flours still need attention to contamination; teach label checking and avoidance of cross-contact through utensils, cooking surfaces and toasters. [1]
- Ensure adequate fibre and correct deficiencies such as iron, folate, calcium or vitamin B12. Use clinical review and appropriate baseline/follow-up testing, including blood count, iron status, coeliac serology, calcium and vitamin D, to guide nutritional care. [1]
Monitor response and investigate persistent symptoms
- Arrange clinical and dietetic follow-up after diagnosis. The resource-rich cascade recommends antibody monitoring after 3–6 months in the first year and annually thereafter when stable and responding; individualise review when symptoms or abnormalities persist. [1]
- Falling or normalised antibodies support reduced gluten exposure but do not prove complete adherence or mucosal healing. Trace gluten can escape serological detection; rising titres after normalisation suggest renewed exposure and should trigger dietary review. [1]
- With persistent symptoms, first reassess gluten exposure and the original diagnosis, then consider overlapping IBS, lactose intolerance, pancreatic insufficiency, microscopic colitis, bacterial overgrowth and other pathology. The source considers repeat intestinal biopsy necessary for persistent symptoms despite a strict gluten-free diet. [1]
- Monitor children and adolescents annually for growth, pubertal development and coeliac serology until final height, with paediatric expertise. Plan a structured transition to adult care that addresses diet, monitoring and psychological needs. [1]
Limitations and use
- This is WGO guidance published in 2016, not a newly issued diagnostic standard. Current paediatric/adult biopsy-sparing criteria, gluten-challenge protocols, vaccine indications and refractory-disease treatment are not specified here and require current specialist guidance.
- The dietary recommendations require individual dietetic assessment. Oat introduction and quantitative gluten-exposure limits are not resolved by this summary; product contamination and tolerance must be considered.
- Resource-sensitive options do not make clinical response alone a reliable diagnosis when serology or biopsy is accessible. In India, alternative causes of villous injury and laboratory/pathology expertise materially affect interpretation.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Coeliac disease: WGO global guideline
Selected recommendation material consulted
Publication details
- Issuing organisation
- World Gastroenterology Organisation
- Resource type
- Clinical guideline · House clinical summary
Earlier House summaries: coeliac disease acg
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.